IDiyas

For the Inventor, By the Inventor

Superior, CO, United States of America

Donghua Dai

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 14.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Boulder, CO (US) (2022 - 2023)
  • Superior, CO (US) (2022 - 2024)
  • Indianapolis, IN (US) (2024)

Company Filing History:

goldMedal6 out of 329 
 
Array Biopharma Inc.
 patents
silverMedal2 out of 38 
 
Mirati Therapeutics, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2022-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 11964989 - KRas G12D inhibitors (2024-04-23),
2. 11964988 - Fused heterocyclic compounds as RET kinase inhibitors (2024-04-23),
3. 11603374 - Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors (2023-03-14),
4. 11524963 - Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors (2022-12-13),
5. 11472802 - Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors (2022-10-18),
6. 11453683 - KRas G12D inhibitors (2022-09-27),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…